In-vivo, LIF was previously shown to significantly enhance radioresistance in a NPC xenograft model whereby the administration of soluble LIF following one dose of 7 Gy irradiation significantly enhanced resistance to radiation and promoted tumour growth [22]. The gene discussed is LIF; the disease is nasopharyngeal carcinoma.